Intech Biopharm Shares Outstanding vs. Total Debt
| 6461 Stock | TWD 25.85 0.05 0.19% |
For Intech Biopharm profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Intech Biopharm to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Intech Biopharm utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Intech Biopharm's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Intech Biopharm over time as well as its relative position and ranking within its peers.
Intech |
Intech Biopharm Total Debt vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Intech Biopharm's current stock value. Our valuation model uses many indicators to compare Intech Biopharm value to that of its competitors to determine the firm's financial worth. Intech Biopharm is rated below average in shares outstanding category among its peers. It is the top company in total debt category among its peers making up about 8.04 of Total Debt per Shares Outstanding. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Intech Biopharm's earnings, one of the primary drivers of an investment's value.Intech Total Debt vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Intech Biopharm |
| = | 116.96 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Intech Biopharm |
| = | 940.77 M |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
Intech Total Debt vs Competition
Intech Biopharm is the top company in total debt category among its peers. Total debt of Biotechnology industry is presently estimated at about 3.21 Billion. Intech Biopharm totals roughly 940.77 Million in total debt claiming about 29% of stocks in Biotechnology industry.
Intech Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Intech Biopharm. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Intech Biopharm position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Intech Biopharm's important profitability drivers and their relationship over time.
Learn to be your own money manager
Our tools can tell you how much better you can do entering a position in Intech Biopharm without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Efficient Frontier Now
Efficient FrontierPlot and analyze your portfolio and positions against risk-return landscape of the market. |
| All Next | Launch Module |
Use Investing Themes to Complement your Intech Biopharm position
In addition to having Intech Biopharm in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run FinTech Thematic Idea Now
FinTech
High long term potential financial entities that are ranging from payment processing, investment management to commercial and investment banking. The FinTech theme has 69 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize FinTech Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Intech Stock Analysis
When running Intech Biopharm's price analysis, check to measure Intech Biopharm's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Intech Biopharm is operating at the current time. Most of Intech Biopharm's value examination focuses on studying past and present price action to predict the probability of Intech Biopharm's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Intech Biopharm's price. Additionally, you may evaluate how the addition of Intech Biopharm to your portfolios can decrease your overall portfolio volatility.